Therapeutic T cells with desired specificity can be engineered by introducing T-cell receptors
(TCRs) specific for antigens of interest, such as those from pathogens or tumour cells. …

Adoptive transfer of T cells expressing a transgenic T cell receptor (TCR) has the potential to
revolutionize immunotherapy of infectious diseases and cancer. However, the generation of …

T cell activation is a cornerstone in manufacturing of T cell-based therapies, and precise control
over T cell activation is important in the development of the next generation T-cell based …

Cell alterations during isolation and preparation for flow cytometry cell sorting by antibodies,
temperature, homogenization, buffer composition and mitogens are well known. In contrast, …

Background Enteral nutrition is used to treat a subset of patients with inflammatory bowel
diseases. Because dietary factors may contribute to an aggressive immune response toward …

Peptide-MHC (pMHC) multimers have become a valuable tool for immunological research,
clinical immune monitoring, and immunotherapeutic applications. Biotinylated tetramers, …

Immunotherapy can revolutionize anti-cancer therapy if specific targets are available.
Immunogenic peptides encoded by cancer-specific genes (CSGs) may enable targeted …

Large-scale target cell isolation from patient blood preparations is one of the critical
operations during drug product manufacturing for personalized cell therapy in immuno-oncology. …

Background Neoantigens derived from somatic mutations correlate with therapeutic responses
mediated by treatment with immune checkpoint inhibitors. Neoantigens are therefore …

CAR T cell therapy is a rapidly growing area of oncological treatments having a potential of
becoming standard care for multiple indications. Coincidently, CRISPR/Cas gene-editing …